Abstract Background: Genetic cascade screening is the most cost-effective method for the identification of individuals with familial hypercholesterolemia (FH), but the best strategies for the enrollment of at-risk individuals in a FH screening program are not fully known. Objective: The aim of this study is to identify the best predictors of familial enrollment into genetic screening, using features derived from tested probands. Methods: One hundred and eighty-three index-cases (ICs) with a positive genetic result that had relatives screened from 01/2011 to 07/2015 were included. The response variable was the number of relatives for each enrolled IC. All variables in the study were based on ICs’ derived clinical and socioeconomical featu...
Background: cascade testing the relatives of people with familial hypercholesterolaemia is an effici...
BACKGROUND: In the majority of people with familial hypercholesterolaemia (FH) the disorder is cause...
Background and aims: Familial hypercholesterolaemia (FH) is an autosomal-dominant disease with f...
Abstract Background: Genetic cascade screening is the most cost-effective method for the identifica...
Background and Aims: The large-scale implementation and effectiveness of genetic cascade screening f...
Objectives To determine what proportion of cases of heterozygous familial hypercholesteroloemia woul...
Background: Familial hypercholesterolaemia (FH) is a co-dominantly inherited disorder of low-density...
OBJECTIVES: To determine what proportion of cases of heterozygous familial hypercholesterolaemia wou...
AIMS: Familial hypercholesterolaemia (FH) is an autosomal dominant disease that warrants early diagn...
To inform guidelines for screening family members of patients with familial hypercholesterolemia (FH...
Familial hypercholesterolaemia (FH) is an autosomal dominant disease that warrants early diagnosis t...
Background: The Dutch cascade screening model for FH was the most successful of such programs in the...
Background: Familial hypercholesterolemia (FH) imposes significant burden of premature coronary hear...
Background and aims: Cascade testing in relatives of index cases is the most cost-effective approac...
textabstractFamilial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by ab...
Background: cascade testing the relatives of people with familial hypercholesterolaemia is an effici...
BACKGROUND: In the majority of people with familial hypercholesterolaemia (FH) the disorder is cause...
Background and aims: Familial hypercholesterolaemia (FH) is an autosomal-dominant disease with f...
Abstract Background: Genetic cascade screening is the most cost-effective method for the identifica...
Background and Aims: The large-scale implementation and effectiveness of genetic cascade screening f...
Objectives To determine what proportion of cases of heterozygous familial hypercholesteroloemia woul...
Background: Familial hypercholesterolaemia (FH) is a co-dominantly inherited disorder of low-density...
OBJECTIVES: To determine what proportion of cases of heterozygous familial hypercholesterolaemia wou...
AIMS: Familial hypercholesterolaemia (FH) is an autosomal dominant disease that warrants early diagn...
To inform guidelines for screening family members of patients with familial hypercholesterolemia (FH...
Familial hypercholesterolaemia (FH) is an autosomal dominant disease that warrants early diagnosis t...
Background: The Dutch cascade screening model for FH was the most successful of such programs in the...
Background: Familial hypercholesterolemia (FH) imposes significant burden of premature coronary hear...
Background and aims: Cascade testing in relatives of index cases is the most cost-effective approac...
textabstractFamilial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by ab...
Background: cascade testing the relatives of people with familial hypercholesterolaemia is an effici...
BACKGROUND: In the majority of people with familial hypercholesterolaemia (FH) the disorder is cause...
Background and aims: Familial hypercholesterolaemia (FH) is an autosomal-dominant disease with f...